A small number of cancers (basal cell carcinoma, breast cancer, malignant melanoma, lipoma, squamous cell carcinoma) were reported during the 12-week oral METAOD005 trial
Flexible 5mg and 50mg Vial Sizing What it is: Two distinct lyophilized vial options catering to different scales of research
352.204.0094 [gtranslate] We do NOT answer medical questions online or via text
Frontier Peptide Labs does not provide dosing, administration, human-use, veterinary-use, diagnostic, cosmetic, or therapeutic guidance
Symptoms include fatigue, weakness, intestinal problems, nerve issues, pain, anxiety, depression, and metabolism
What matters more than the momentary discomfort is whether the program is administered appropriately and whether the patient fully understands why the injection is being used, what it is expected to do, and its medical limitations